Financhill
Back

MoonLake Immunotherapeutics Stock Predictions

MoonLake Immunotherapeutics Stock Forecast

  • Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 102.2% based on the past 4 years of stock performance.
  • MoonLake Immunotherapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is MoonLake Immunotherapeutics Stock Undervalued?
    The current MoonLake Immunotherapeutics [MLTX] share price is $54.43. The Score for MLTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • MLTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will MoonLake Immunotherapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 102.2% based on the past 4 years of stock performance.

MoonLake Immunotherapeutics Stock Rating

Buy
77
MoonLake Immunotherapeutics (MLTX) is a Buy

Is MoonLake Immunotherapeutics overpriced?

  • MoonLake Immunotherapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

MoonLake Immunotherapeutics Stock Price History

Is MLTX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLTX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
moonlaketx.com

52-Week Data

52-Week High:
64.98
52-Week Low:
37.55

Prediction Charts

Market Cap:
3.43B
Price in USD:
54.43
Volume:
58.33K
Beta:
1.29

Technical Analysis

SMA50:
50.27
SMA100:
48.47
SMA200:
46.64
52-Wk Change:
28.71%

Stock Predictions

  • Is MoonLake Immunotherapeutics stock public?
    Yes, MoonLake Immunotherapeutics is a publicly traded company.
  • What is the MoonLake Immunotherapeutics stock quote today?
    The MoonLake Immunotherapeutics stock price is 54.43 USD today.
  • How to buy MoonLake Immunotherapeutics stock online?
    You can buy MoonLake Immunotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-11 52.00 53.89 54.26 51.42
Nov-12 53.72 51.89 54.81 51.51
Nov-13 52.36 51.06 53.18 50.93
Nov-14 50.63 52.50 52.96 50.28
Nov-15 51.98 48.83 52.24 48.30
Nov-18 48.80 48.54 49.29 47.33
Nov-19 48.23 49.33 49.48 48.23
Nov-20 49.44 49.82 50.98 48.97
Nov-21 50.07 51.86 52.09 48.91
Nov-22 52.30 54.32 54.93 51.43
Nov-25 54.99 54.17 55.81 53.88
Nov-26 54.21 52.84 54.33 52.15
Nov-27 53.09 54.24 54.60 52.37
Nov-29 54.86 54.43 55.37 54.43

MoonLake Immunotherapeutics Earnings

MoonLake Immunotherapeutics Earnings Report: Per Share MoonLake Immunotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

MoonLake Immunotherapeutics Forecast Revenue Growth

MoonLake Immunotherapeutics Stock Analysis: Historical quarterly revenues per share for MoonLake Immunotherapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.87 per share, and a decrease next year of $0.72 per share.

* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.